ELYM: Eliem Therapeutics, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati

eliemtx.com (ELYM) tovar belgisi

Eliem Therapeutics (ELYM) biotexnologiya inkubatorlari bilan ittifoqlar va M&A tranzaksiyalari orqali o'zining neyrofarmatsevtika yo'nalishini kengaytirmoqda. O'sishga normallashtirilgan P/E ko'rsatkichi aksiya narxi va foyda dinamikasi orasidagi nisbatni vizuallashtiradi, bunda 0.00 qiymati eng so'nggi raqamni ifodalaydi. Biznesning rivojlanishi bozor sikllariga emas, balki klinik ma'lumotlarga bog'liq, R&D pudratchilari bazasini optimallashtirish esa sinovlarning moslashuvchanligini ta'minlaydi.

ELYM Eliem Therapeutics, Inc. Narxning foydaga va o‘sish sur’atiga nisbati (04.07.2022 - 03.10.2024)

Eliem Therapeutics (ELYM) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning umumiy tahlili:Eliem Therapeutics, Inc., ELYM
Eliem tayyor mahsulotlari

Neyroinflammasiya uchun inqilobiy davolash usullarini ishlab chiqadigan biotexnologiya innovatori Eliem Therapeutics (ELYM) uchun bozor qiymati va foyda kengayish sur'ati o'rtasidagi korrelyatsiya juda muhimdir. Ushbu ko'rsatkich P/E koeffitsientini sof foydaning yillik o'sishi bilan solishtirib, joriy aksiya narxining biznesning fundamental dinamikasi bilan qanchalik asoslanganligini aniqlaydi. O'sishga yo'naltirilgan kompaniyalar uchun past baholanganlik metriklari tahlil qilish orqali, investor qiymat birlikdan pastga tushganda keskin yuksalish potentsialiga ega bo'lgan aktivlarni aniqlaydi.

Raqobatdosh kompaniyalar

Narxning foydaga va o‘sish sur’atiga nisbati BIIB (Biogen Inc)|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Regencell Corp (RGC)|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acadia-pharm.com|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Viking Therapeutics Inc|Narx-foyda va o‘sish multiplikatori SUPN|CPRX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati HRMY|PEG multiplikatori BHVN (Biohaven)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AMLX|Trevi Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Praxis Corp|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PRTA (Prothena Corporation plc) - PEG multiplikatori|PEG multiplikatori Alector Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|OMER: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori NGNE (Neurogene Inc.)|acimmune.com (ACIU) - O‘sish sur’atiga tuzatilgan narx-foyda|VYGR: Narx-foyda va o‘sish multiplikatori|NMRA - PEG multiplikatori|SCLX (Scilex Holding Co.) - Narx-foyda va o‘sish multiplikatori|TVGN: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ACOG (Alpha Cognition Inc) - PEG multiplikatori|cogrx.com (CGTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori IKT|Narx-foyda va o‘sish multiplikatori Cassava Sciences Inc SAVA|Narxning foydaga va o‘sish sur’atiga nisbati Assertio ASRT|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Coya Therapeutics Inc (COYA)|VistaGen Therapeutics Inc - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Ovid Therapeutics Inc.|Acumen Pharmaceuticals, Inc. (ABOS) - Narxning foydaga va o‘sish sur’atiga nisbati|CRVO (CervoMed, Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori ATHE|O‘sish sur’atiga tuzatilgan narx-foyda Clene Nanomedicine CLNN|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|Narx-foyda va o‘sish multiplikatori jupiterneurosciences.com JUNS|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Grace Tx - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Firefly Neuro|KLTO (anewmeds.com) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics Ltd. (NRSN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|MTVA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NeurAxis, Inc (NRXS)|HSDT - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori PASG (Passage Bio)|Neuphoria Therapeutics, Inc. (NEUP) - O‘sish sur’atiga tuzatilgan narx-foyda|NERV - Narxning foydaga va o‘sish sur’atiga nisbati|ATHA: Narxning foydaga va o‘sish sur’atiga nisbati|ADXN: PEG multiplikatori|ALZN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CYCN (Cyclerion Therapeutics Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Protagenic PTIX|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|Narx-foyda va o‘sish multiplikatori cortigent.com CRGT|Avenue Therapeutics, Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BCLI|CARA: Narx-foyda va o‘sish multiplikatori|chromocell.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ITCI: PEG multiplikatori|Longboard Pharmaceuticals Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|MRNS (Marinus) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech Corp NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SNPX (Synaptogenix)|PEG multiplikatori Trevena Inc. TRVN|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati WENA|CERE: PEG multiplikatori